首页 > 市场调查报告书 > 製药

个人化医学

市场调查报告书

商品编码

1908010

伴随诊断市场按技术类型、应用、最终用户和地区划分

Companion Diagnostics Market, By Technology Type, By Application, By End User, By Region

出版日期: 2025年12月24日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2025 年，伴随诊断市场规模将达到 87.6 亿美元，到 2032 年将达到 197.3 亿美元，2025 年至 2032 年的复合年增长率为 12.3%。

报告内容		报告详情
基准年：	2024	2025年市场规模：	87.6亿美元
历史数据时期：	2020年至2024年	预测期：	2025年至2032年
预测期（2025-2032年）复合年增长率：	12.30%	2032 年的预测值：	197.3亿美元

伴随诊断是一种用于检测患者体内特定生物标记或基因的医疗设备，有助于确定哪些患者最适合接受特定治疗方法。这些诊断在个人化医疗中发挥着重要作用，能够帮助医生为癌症和其他疾病选择合适的标靶治疗。伴随诊断测试评估与患者对特定药物的反应相关的生物标记（例如蛋白质、基因或染色体）的表达量。分析这些生物标记的表达量有助于确定特定药物对特定患者或患有特定疾病的患者群体是否安全有效。这确保了只有合适的患者才能接受专门治疗，从而改善治疗效果。

市场动态

全球伴随诊断市场的发展动力主要来自对个人化医疗日益增长的需求、分子诊断技术的进步、新型标靶治疗和伴随诊断核准的增加、技术进步以及癌症和其他慢性疾病发生率和盛行率的上升。然而，与这些分子诊断测试的开发和商业化相关的高定价压力和复杂的监管问题可能会阻碍因素市场成长。此市场的主要机会包括：开髮用于免疫疗法的生物标记和伴随诊断；拓展在非肿瘤疾病领域的应用；体外诊断（IVD）公司与製药公司在精准医疗领域的合作；新兴市场对伴随诊断开发的日益重视；以及采用次世代定序（NGS）等先进技术进行生物标誌物检测。

本次调查的主要特点

本报告对全球伴随诊断市场进行了详细分析，以 2024 年为基准年，给出了 2025 年至 2032 年的市场规模（十亿美元）和復合年增长率（%）。
它还重点介绍了各个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
本报告根据以下参数对全球伴随诊断市场的主要企业参与者进行了分析：公司概况、产品系列、主要亮点、财务绩效和策略。
本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球伴随诊断市场报告涵盖了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
相关人员可以透过各种用于分析全球伴随诊断市场的策略矩阵，更轻鬆地做出决策。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
非洲
- 南非
- 北非
- 中非

第八章竞争情势

公司简介
- F.Hoffmann-La Roche AG
- Agilent Technologies, Inc
- QIAGEN NV
- Abbott Laboratories, Inc.
- Almac Group
- Danaher Corporation
- Illumina, Inc
- bioMerieux SA
- Myriad Genetics, Inc
- Sysmex Corporation
- Thermo Fisher Scientific Inc
- Abnova Corporation
- Guardant Health, Inc.
- Icon Plc
- Biogenex Laboratories, Inc

第九章各节

参考
调查方法
关于本公司

简介目录

Product Code: CMI109

Companion Diagnostics Market is estimated to be valued at USD 8.76 Bn in 2025 and is expected to reach USD 19.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 8.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.30%	2032 Value Projection:	USD 19.73 Bn

Companion diagnostics are medical devices that are used to detect specific biomarkers or genes in patients that help determine which patients are most suitable candidates for a particular therapy. These diagnostics play an important role in personalized healthcare by helping physicians select appropriate targeted treatment options for cancer and other diseases. Companion diagnostics tests evaluate the expression of biomarkers, such as proteins, genes or chromosomes that plays a role in a patient's response to a specific drug. By analyzing the expression levels of such biomarkers, these tests help to identify whether a particular drug would be safe and effective for a specific patient or set of patients with a given disease. This enables better therapeutic outcomes by ensuring only suitable patients receive specialized treatments.

Market Dynamics

Global companion diagnostics market is driven by rising demand for personalized medicine, growth in molecular diagnostics, increasing approvals of new targeted therapies & companion diagnostics, technological advancements, and growing incidence and prevalence of cancer, and other chronic diseases. However, the market growth can be restricted by high pricing pressure and regulatory hassles that are involved in developing and commercializing these molecular diagnostic tests. Key opportunities in this market include developing biomarkers and companion diagnostics for immunotherapies, expanding applications in non-oncology diseases, precision medicine collaborations between In vitro diagnostics (IVD) companies and drug makers, growing focus on companion diagnostic development in emerging markets, and adoption of advanced technologies like Next-generation sequencing (NGS) for biomarker detection.

Key features of the study

This report provides in-depth analysis of the global companion diagnostics market, and provides market size (USD Bn)and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global companion diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Agilent Technologies, Inc., QIAGEN N.V, Abbott Laboratories, Inc., Almac Group, Danaher Corporation, Illumina, Inc., bioMerieux SA, Myriad Genetics, Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Abnova Corporation, Guardant Health, Inc., Icon Plc., and Biogenex Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global companion diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion diagnostics market

Market Segmentation

By Technology Type
- Real Time-Polymerase Chain Reactions (PCR)
- Gene Sequencing
- Fluorescence in situ Hybridization
- Others
By Application
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Neurological Diseases
- Others
By End User
- Hospitals
- Research Laboratories
- Biopharmaceutical companies
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Hoffmann-La Roche AG
- Agilent Technologies, Inc
- QIAGEN N.V
- Abbott Laboratories, Inc.
- Almac Group
- Danaher Corporation
- Illumina, Inc.
- bioMerieux SA
- Myriad Genetics, Inc.
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Abnova Corporation
- Guardant Health, Inc.
- Icon Plc.,
- Biogenex Laboratories, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Technology Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing number of cancer patients
- Complexity of Integration
- Emerging markets
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Companion Diagnostics Market, By Technology Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Real Time-Polymerase Chain Reactions (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gene Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fluorescence in situ Hybridization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Companion Diagnostics Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurological Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Companion Diagnostics Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biopharmaceutical companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Companion Diagnostics Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Company Profiles
- F.Hoffmann-La Roche AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Agilent Technologies, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- QIAGEN N.V
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Abbott Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Almac Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Danaher Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Illumina, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- bioMerieux SA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Myriad Genetics, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sysmex Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Abnova Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Guardant Health, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Icon Plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Biogenex Laboratories, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
  - Analysts' Views

9. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

伴随诊断市场按技术类型、应用、最终用户和地区划分

Companion Diagnostics Market, By Technology Type, By Application, By End User, By Region

市场动态